Author Correction: Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes.

Journal

Nature medicine
ISSN: 1546-170X
Titre abrégé: Nat Med
Pays: United States
ID NLM: 9502015

Informations de publication

Date de publication:
Oct 2020
Historique:
pubmed: 9 9 2020
medline: 9 9 2020
entrez: 8 9 2020
Statut: ppublish

Résumé

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiants

DOI: 10.1038/s41591-020-1078-y PMID: 32895574
pubmed: 32895574
doi: 10.1038/s41591-020-1078-y
pii: 10.1038/s41591-020-1078-y
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

1663

Subventions

Organisme : NCI NIH HHS
ID : T32 CA009172
Pays : United States

Commentaires et corrections

Type : ErratumFor

Auteurs

Pier Vitale Nuzzo (PV)

Department of Medical Oncology, The Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genoa, Genoa, Italy.
ORCID: 0000-0002-5618-8079

Jacob E Berchuck (JE)

Department of Medical Oncology, The Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
ORCID: 0000-0002-7607-2428

Keegan Korthauer (K)

Department of Statistics, University of British Columbia, Vancouver, British Columbia, Canada.
BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.

Sandor Spisak (S)

Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

Amin H Nassar (AH)

Department of Medical Oncology, The Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
ORCID: 0000-0002-8084-9105

Sarah Abou Alaiwi (SA)

Department of Medical Oncology, The Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

Ankur Chakravarthy (A)

Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

Shu Yi Shen (SY)

Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
ORCID: 0000-0001-7036-2291

Ziad Bakouny (Z)

Department of Medical Oncology, The Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
ORCID: 0000-0003-1906-5704

Francesco Boccardo (F)

Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genoa, Genoa, Italy.
Academic Unit of Medical Oncology, IRCCS San Martino Polyclinic Hospital, Genoa, Italy.

John Steinharter (J)

Department of Medical Oncology, The Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

Gabrielle Bouchard (G)

Department of Medical Oncology, The Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

Catherine R Curran (CR)

Department of Medical Oncology, The Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

Wenting Pan (W)

Department of Medical Oncology, The Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

Sylvan C Baca (SC)

Department of Medical Oncology, The Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
The Eli and Edythe L. Broad Institute, Cambridge, MA, USA.

Ji-Heui Seo (JH)

Department of Medical Oncology, The Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

Gwo-Shu Mary Lee (GM)

Department of Medical Oncology, The Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

M Dror Michaelson (MD)

Massachusetts General Hospital Cancer Center, Hematology/Oncology, Boston, MA, USA.

Steven L Chang (SL)

Division of Urology, Brigham and Women's Hospital, Boston, MA, USA.

Sushrut S Waikar (SS)

Division of Renal Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Section of Nephrology, Boston University Medical Center, Boston, MA, USA.

Guru Sonpavde (G)

Department of Medical Oncology, The Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

Rafael A Irizarry (RA)

Department of Biostatistics, Harvard University, Cambridge, MA, USA.
Department of Data Sciences, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

Mark Pomerantz (M)

Department of Medical Oncology, The Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

Daniel D De Carvalho (DD)

Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
ORCID: 0000-0002-8572-5259

Toni K Choueiri (TK)

Department of Medical Oncology, The Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. toni_choueiri@dfci.harvard.edu.
The Eli and Edythe L. Broad Institute, Cambridge, MA, USA. toni_choueiri@dfci.harvard.edu.
ORCID: 0000-0002-9201-3217

Matthew L Freedman (ML)

Department of Medical Oncology, The Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. mfreedman@partners.org.
Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. mfreedman@partners.org.
The Eli and Edythe L. Broad Institute, Cambridge, MA, USA. mfreedman@partners.org.
ORCID: 0000-0001-9249-6338

Classifications MeSH